Literature DB >> 20048026

Acetaminophen: old drug, new warnings.

Amy Schilling1, Rebecca Corey, Mandy Leonard, Bijan Eghtesad.   

Abstract

The US Food and Drug Administration (FDA), concerned about the incidence of acute liver failure due to acetaminophen (Tylenol) overdose, has mandated new labeling on acetaminophen packaging. It is also considering (but has not enacted) reducing the maximum daily dose from 4 g (possibly to 3,250 mg), banning acetaminophen-narcotic combination products, and changing the current maximum single dose of 1 g to prescription status, making 650 mg the highest recommended nonprescription dose. We review the epidemiology, toxicology, and management of acetaminophen overdose and steps the FDA and physicians can take to prevent it.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048026     DOI: 10.3949/ccjm.77a.09084

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  18 in total

Review 1.  Viscosupplementation for osteoarthritis: a primer for primary care physicians.

Authors:  M Carrington Reid
Journal:  Adv Ther       Date:  2013-11-08       Impact factor: 3.845

2.  Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver.

Authors:  Jiangting Hu; Venkat K Ramshesh; Mitchell R McGill; Hartmut Jaeschke; John J Lemasters
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

3.  Patterns of acetaminophen use exceeding 4 grams daily in a hospitalized population at a tertiary care center.

Authors:  Jesse M Civan; Victor Navarro; Steven K Herrine; Jeffrey M Riggio; Paul Adams; Simona Rossi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

4.  Treatment of acute migraine in the pediatric population.

Authors:  Hope L O'Brien; Marielle A Kabbouche; Andrew D Hershey
Journal:  Curr Treat Options Neurol       Date:  2010-05       Impact factor: 3.598

Review 5.  Topical therapies for osteoarthritis.

Authors:  Roy D Altman; H Richard Barthel
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

6.  Treatment of pediatric migraine.

Authors:  Hope L O'Brien; Marielle A Kabbouche; Joanne Kacperski; Andrew D Hershey
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

7.  A Randomized Placebo-Controlled Trial of Efficacy and Safety: Drug-Free Gel Containing Ultra-Deformable Phospholipid Vesicles (TDT 064) in Osteoarthritic Knees.

Authors:  Varah Yuenyongviwat; Khanin Iamthanaporn; Pakjai Tuntarattanapong; Theerawit Hongnaparak; Boonsin Tangtrakulwanich
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2021-07-28

8.  Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study.

Authors:  Roderick Clark; Judith E Fisher; Ingrid S Sketris; Grace M Johnston
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

9.  Gene expression in rat hearts following oral administration of a single hepatotoxic dose of acetaminophen.

Authors:  Seon Mi Jin; Hong Ryang Kil; Kwangsik Park; Chung Il Noh
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

10.  The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model.

Authors:  Rotem Ben-Shachar; Yifei Chen; Shishi Luo; Catherine Hartman; Michael Reed; H Frederik Nijhout
Journal:  Theor Biol Med Model       Date:  2012-12-19       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.